T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.55% |
| 2 | Healthcare | 16.29% |
| 3 | Consumer Discretionary | 15.56% |
| 4 | Financials | 12.85% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Howard Hughes
HHH
$4B
| $26.7M | ﹤0.01% |
293,989
+274,505
| +1,409% | +$24.1M |
|
|
K
1202
DELISTED
Kellanova
K
| $26.6M | ﹤0.01% |
447,034
-31,324
| -7% | -$1.75M |
|
1203
NetApp
NTAP
$39.9B
| $26.5M | ﹤0.01% |
364,619
-20,215
| -5% | -$1.36M |
|
1204
First Bancorp
FBNC
$2.76B
| $26.4M | ﹤0.01% |
607,597
-37,395
| -6% | -$1.49M |
|
1205
Stepan Co
SCL
$1.47B
| $26.3M | ﹤0.01% |
207,201
-2,587
| -1% | -$321K |
|
1206
Blackstone
BX
$110B
| $26.3M | ﹤0.01% |
352,961
-2,793
| -0.8% | -$193K |
|
|
LPRO
1207
DELISTED
Open Lending Corp
LPRO
| $26.1M | ﹤0.01% |
737,999
-731,037
| -50% | -$27.6M |
|
|
VAR
1208
DELISTED
Varian Medical Systems, Inc.
VAR
| $26.1M | ﹤0.01% |
147,802
-9,594
| -6% | -$1.69M |
|
1209
Innovative Industrial Properties
IIPR
$1.66B
| $26M | ﹤0.01% |
144,055
+15,204
| +12% | +$2.91M |
|
|
AKRO
1210
DELISTED
Akero Therapeutics
AKRO
| $25.9M | ﹤0.01% |
893,146
+235,691
| +36% | +$7.13M |
|
1211
BlackLine
BL
$1.77B
| $25.7M | ﹤0.01% |
237,338
+153,772
| +184% | +$19.2M |
|
1212
Steel Dynamics
STLD
$37.6B
| $25.7M | ﹤0.01% |
506,531
-24,660
| -5% | -$1.04M |
|
1213
Cincinnati Financial
CINF
$26.6B
| $25.6M | ﹤0.01% |
248,647
-17,239
| -6% | -$1.65M |
|
1214
Blackstone Mortgage Trust
BXMT
$2.46B
| $25.5M | ﹤0.01% |
822,965
+1,875
| +0.2% | +$54.5K |
|
1215
Pacira BioSciences
PCRX
$916M
| $25.5M | ﹤0.01% |
363,963
-5,326
| -1% | -$380K |
|
1216
Hexcel
HXL
$7.78B
| $25.5M | ﹤0.01% |
455,268
-241,742
| -35% | -$12.7M |
|
1217
Masco
MAS
$14.6B
| $25.4M | ﹤0.01% |
424,486
-36,735
| -8% | -$2.05M |
|
1218
Q32 Bio
QTTB
$459M
| $25.3M | ﹤0.01% |
149,537
+39,187
| +36% | +$8.25M |
|
1219
DaVita
DVA
$11.5B
| $25.3M | ﹤0.01% |
234,418
-64,643
| -22% | -$7.18M |
|
1220
Seagate
STX
$221B
| $24.8M | ﹤0.01% |
323,018
-58,911
| -15% | -$4.1M |
|
1221
TherapeuticsMD
TXMD
$23.8M
| $24.5M | ﹤0.01% |
366,260
-11,124
| -3% | -$871K |
|
1222
Kimbell Royalty Partners
KRP
$1.54B
| $24.5M | ﹤0.01% |
2,411,955
-126,177
| -5% | -$1.22M |
|
1223
Alarm.com
ALRM
$2.72B
| $24.4M | ﹤0.01% |
282,727
+78,621
| +39% | +$7.41M |
|
|
SNCY
1224
DELISTED
Sun Country Airlines
SNCY
| $24.4M | ﹤0.01% |
+711,300
| New | +$24.1M |
|
1225
iShares Russell 1000 Growth ETF
IWF
$129B
| $24.4M | ﹤0.01% |
400,880
+263,832
| +193% | +$16.1M |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.